Previous Article | Next Article 
Journal of Clinical Microbiology, January 2001, p. 47-50, Vol. 39, No. 1
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.47-50.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Epidemiology of Scedosporium
apiospermum Infection Determined by PCR Amplification of Ribosomal
Intergenic Spacer Sequences in Patients with Chronic Lung
Disease
Emma C. M.
Williamson,1,*
David
Speers,1
Ian H.
Arthur,1
Gerald
Harnett,1
Gerard
Ryan,2 and
Tim J. J.
Inglis1
Division of Microbiology and Infectious
Diseases, The Western Australian Center for Pathology and Medical
Research (PathCentre),1 and Department
of Respiratory Medicine, Sir Charles Gairdner
Hospital,2 Nedlands 6009, Australia
Received 28 March 2000/Returned for modification 10 May
2000/Accepted 11 October 2000
 |
ABSTRACT |
Respiratory tract colonization with Scedosporium
apiospermum in patients with chronic suppurative lung disease is
a significant concern for lung transplantation candidates, since
Scedosporium infections occurring posttransplantation are
usually untreatable. Up to 10% of patients with cystic fibrosis
attending our respiratory medicine unit have had
Scedosporium organisms isolated from sputum samples. We
therefore developed a molecular typing method to examine these
isolates. Typing by PCR amplification of ribosomal intergenic spacer
sequences demonstrated 20 different types from 52 isolates collected
from the respiratory medicine unit and elsewhere in Australia. A single
common type was isolated from 11 respiratory medicine unit inpatients.
Two other types were isolated from more than one source: one from two
respiratory medicine unit inpatients and one from two epidemiologically
linked nonhuman sources. Multiple isolates were obtained from nine
patients. This method demonstrated persistent carriage of isolates of
the same type in one patient for 7 months. Two patients showed carriage
of isolates with multiple typing patterns within a 3-month period. The
high rate of isolation and the predominance of isolates with a single
typing pattern from respiratory medicine unit patients may suggest
transmission to patients from a source in the unit. There was no
epidemiological evidence of direct patient-to-patient spread, and
Scedosporium organisms were not isolated from dust, soil,
or air samples from the unit. The source and route of transmission have
yet to be determined.
 |
INTRODUCTION |
Scedosporium apiospermum
(perfect state, Pseudallescheria boydii) is a saprophytic
mold with a worldwide distribution and a reservoir in soil. The most
commonly described clinical problem associated with this fungus is
Madura foot, a cutaneous mycetoma that follows spore implantation.
S. apiospermum has also been reported to cause pneumonia in
previously immunocompetent hosts after near-drowning incidents in water
contaminated with soil or animal manure (1).
Immunocompromised patients, including those with hematological
malignancy or undergoing bone marrow or solid-organ transplantation,
may suffer fatal pulmonary, sinus, and disseminated infections
(4, 5, 10, 13). Patients with cavitating or chronic
suppurative lung diseases may develop clinical problems similar to
those caused by Aspergillus fumigatus, the most common being
respiratory tract colonization; fungal balls (7) and
allergic bronchopulmonary disease (9) have also been
reported. S. apiospermum is usually resistant in vitro and in vivo to commonly available antifungal agents, such as itraconazole and amphotericin. There are, however, reports of successful treatment with both systemic miconazole and ketoconazole (2, 16), in some cases combined with surgery (3).
Scedosporium respiratory tract colonization is regarded as a
relative but not absolute contraindication to lung transplantation
(11). Most centers consider such colonized lung transplant
candidates on an individual basis because of these potential
therapeutic difficulties.
We have recently noticed an increase in S. apiospermum
isolates from patients with cystic fibrosis and bronchiectasis
attending our respiratory medicine unit (RMU). As colonization has
serious implications for the future management of some of these
patients, we developed a typing method involving PCR amplification of
ribosomal intergenic spacer sequences (IGS PCR) to elucidate the
epidemiology of S. apiospermum. This is the first reported
typing method for this fungus.
 |
MATERIALS AND METHODS |
Fungal strains.
Consecutive clinical isolates of S. apiospermum identified by the Western Australian Centre for
Pathology and Medical Research Mycology laboratory over a 17-month
period from July 1997 to November 1998 were included in this study.
These isolates were obtained from patients attending the RMU or other
departments of Sir Charles Gairdner Hospital, a tertiary referral
center, and other isolates referred from elsewhere in Western
Australia. Five additional isolates were obtained from centers in other
Australian states. S. apiospermum isolates were identified
by macroscopic and microscopic characteristics. Fungi were subcultured
from primary isolation agar plates onto Sabouraud agar plus 50 mg of
chloramphenicol (Oxoid; supplied by Acorn Biological Pty. Limited,
Victoria Park East, Australia) per liter to confirm purity. Hyphal
fragments were then suspended in sterile water and stored at room temperature.
DNA extraction.
Hyphal fragments from water storage were
subcultured onto Sabouraud agar to confirm purity. Spores were then
inoculated from agar into 5 ml of Sabouraud broth (Oxoid) in a 5-cm
sterile petri dish and incubated at 36°C until a mycelial mat had
formed, at 3 to 5 days. A portion of the mat weighing approximately 10 to 20 mg was removed with sterile forceps, blotted with filter paper to
remove excess liquid, and then suspended in 600 µl of
filter-sterilized sorbitol buffer (1 M sorbitol, 14 mM
beta-mercaptoethanol, 100 mM EDTA) containing 400 U of lyticase
(catalog no. L4025; Sigma) for 1 h at 35°C, with occasional
vortexing. The resultant fungal spheroplasts were precipitated by
centrifugation at 15,000 × g for 5 min, and the
supernatant was discarded. Spheroplasts were resuspended in 200 µl of
proteinase K plus buffer ATL (Qiagen, Clifton Hill, Victoria,
Australia) and incubated overnight in a water bath at 55°C. DNA was
extracted using the Qiagen tissue kit protocol and eluted in 200 µl
of buffer AE. DNA extracts were stored at
25°C. The DNA
concentration was measured spectrophotometrically (Genequant; Pharmacia
Biotech, Cambridge, England). The DNA yield was approximately 200 µg/ml.
PCR protocol.
The primers used span the ribosomal gene
complex IGS region by targeting the conserved 5' end of the 18S
ribosomal gene and the 3' end of the 26S ribosomal gene. Primer
sequences were as follows: forward primer IGSL, 5'-TAG TAC GAG AGG
AAC CGT-3', and reverse primer IGSR, 5'-GCA TAT GAC TAC TGG
CAG-3'. They correspond to bases 120 to 137 and 2285 to 2302 of
the Aspergillus nidulans sequence (EMBL accession number
Z27114) (14). Each PCR mixture contained 1 U of
Taq polymerase (Amplitaq; Perkin-Elmer, Knoxfield, Australia), PCR buffer [67 mM Tris-HCl (pH 8.8), 16.6 mM
(NH4)2SO4, 0.45% Triton X-100, 0.2 mg of
gelatin per ml] (Biotech and Fisher Biotec, Belmont, Australia), 3 mM
MgCl2 (Biotech), a 200 µM concentration of each
deoxynucleoside triphosphate (Boehringer Mannheim and Roche
Diagnostics, Castle View, Australia), a 0.5 µM concentration of each
primer, and 4 µl of a 1-in-10 dilution of DNA extract (approximately
80 ng of DNA). Each reaction mixture was made up to 20 µl with
deionized water treated with diethyl pyrocarbonate (catalog no. D5758;
Sigma) and autoclaved. Reactions were carried out in a Perkin-Elmer
GeneAmp PCR System 9700 thermocycler. Cycling conditions were 1 cycle
of 94°C for 5 min and 45 cycles of denaturing at 94°C for 30 s, annealing at 45°C for 1 min, and extension at 72°C for 1 min,
followed by one final extension step of 72°C for 7 min. All DNA
extracts were assayed in duplicate, and each run included a negative
control of deionized water treated with diethyl pyrocarbonate and
autoclaved. Twenty microliters of PCR product was mixed with 4 µl of
DNA loading dye, and 20 µl of the mixture was run on a 2.8% agarose
gel in Tris acetate buffer and counterstained with ethidium bromide at
60 V for 3 h. Banding patterns were compared visually, with
reference to a 123-bp fragment ladder (Gibco BRL, Life Technologies
Pty. Limited, Mulgrave, Australia). All PCRs were repeated to confirm
reproducibility of banding patterns between runs. All isolates were
subcultured, and DNA extraction and PCR were repeated to confirm strain stability.
RMU setting and environmental sampling.
The RMU consists of
two wards containing a total of 54 beds, a bronchoscopy suite, and
associated offices and occupies a separate block on the hospital site.
This block was constructed approximately 30 years ago as a tuberculosis
isolation unit. RMU outpatients are seen at a different site in the
main hospital block. Dust was collected from various environments on
the RMU using a sterile cotton swab moistened with sterile distilled
water. The locations were the main ward corridor, the bronchoscopy
suite, the cystic fibrosis patients' lounge, the physiotherapy room,
the ward kitchen, and the ward offices. Swabs were spread onto
Sabouraud agar plus chloramphenicol (50 mg/liter) and onto rose bengal
agar plus chloramphenicol (10 mg/liter) (Oxoid) and incubated at 26 and
36°C for 1 week. Surface soil was collected from around the roots of
the two potted plants kept on the RMU. Approximately 10 mg of soil was
mixed with 10 ml of sterile distilled water and agitated briefly, and particulate matter was allowed to precipitate for 5 min. Five microliters of suspension was then cultured onto Sabouraud and rose
bengal media as described above. Air was sampled from within and
immediately outside the RMU using an RCS air sampler (Biotest AG,
Dreieich, Germany). Nutrient agar test strips from the RCS sampler were
incubated at 36°C for 1 week. Fungi were identified using standard
laboratory procedures.
 |
RESULTS |
Patient characteristics.
Fifty-two isolates from 31 sources
(29 patients and two sea turtles [Chelonia mydas]) were
studied (Table 1). The number of isolates
from individual sources ranged from one to nine. Sources were divided
into four epidemiological groups (Table 1): group 1, RMU inpatients;
group 2, RMU outpatients; group 3, other patients from Western
Australia; and group 4, human and nonhuman sources from other states of
Australia. The origins and quantities of isolates were as follows:
respiratory samples, 47; ear swabs, 3; unknown sites (human), 2; and
nonhuman sources, 2. No Scedosporium organisms were isolated
from the environmental samples.
PCR specifications.
PCR was optimized with respect to amount
of DNA, concentrations of Taq polymerase, deoxynucleoside
triphosphates, primers and magnesium, and cycling conditions. The
parameters described resulted in the brightest bands, but the banding
patterns were preserved over a >10-fold range of DNA concentrations, a
range of magnesium chloride concentrations of 2.5 to 3.5 mM, and an annealing temperature down to 40°C (data not shown). Band patterns were reproducible, with the same set of bands being obtained by performing the PCR on different occasions with the same DNA extract.
Types of S. apiospermum.
Analysis was restricted to the
anamorph of the species, S. apiospermum. All isolates were
typeable. This IGS PCR technique allowed the differentiation of 20 distinct types of S. apiospermum. In the absence of a
reference collection of S. apiospermum strains with
corresponding molecular characterizations, a single band difference was
taken to indicate a distinct IGS PCR type (Fig. 1). Repeating the PCR with the same DNA
extract generated the same banding pattern. Each IGS PCR type was
stable on subculture (data not shown). Types B, C, and T were isolated
from more than one source. Type B was isolated from 17 samples taken
from 12 patients. Eleven of these patients were RMU inpatients. Type C was isolated from two RMU inpatients, and type T was isolated from two
sea turtles from Queensland.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
IGS PCR typing patterns of S. apiospermum.
Twenty different types (A through T) are shown in duplicate. Molecular
size standards (in base pairs) are shown in the left-hand lane.
|
|
Length and stability of carriage.
S. apiospermum was
isolated on more than one occasion from each of nine patients. Seven of
these patients had chronic suppurative lung disease. A single IGS PCR
type was isolated from five of these patients, four of which were type
B. One patient had isolates of type C from nine samples over a period
of 7 months. Isolates with two IGS PCR types were isolated from each of
two patients with chronic lung disease within a period of less than 3 months. Two immunocompromised patients with pneumonia had isolates with a single IGS PCR type on multiple bronchial washings and sputum samples. It is unknown whether pneumonia in either patient was caused
by S. apiospermum, since no histological evidence of
invasive fungal infection was obtained.
 |
DISCUSSION |
This is the first report of a typing method for S. apiospermum, a fungus that is emerging as a significant pathogen
in immunocompromised patients. The only previously reported typing
method for Scedosporium spp. has been a randomly amplified
polymorphic DNA method (15) for the closely related
(6) species Scedosporium inflatum. IGS PCR
typing is technically straightforward and reproducible. Similar methods
have been applied to numerous bacteria, including Burkholderia
cepacia (8), and, more recently, to the fungus A. fumigatus (14).
This study has shown how IGS PCR typing may help to elucidate the
epidemiology of S. apiospermum and to define the natural history of human colonization. The ecology of S. apiospermum
bears some similarity to that of A. fumigatus. Both these
environmental organisms are potential colonizers of patients with
chronic suppurative lung disease. The natural history of S. apiospermum colonization appears to be similar to the more fully
described relationship of A. fumigatus with these patients.
We have demonstrated both isolation of S. apiospermum
organisms with the same IGS PCR type over a prolonged period of time
and carriage of multiple isolates of different IGS PCR types over a
period of a few weeks in patients with chronic suppurative lung
disease. Due to the lack of a reference collection with molecular
characterization correlated to epidemiological information, we cannot
conclude at this point whether this represents carriage of multiple
strains or the prolonged carriage of the same strain. These two
observations are, however, analogous to the results obtained for
A. fumigatus typed by randomly amplified polymorphic DNA
analysis (17) and DNA fingerprinting (12) for
patients with cystic fibrosis. Scedosporium sp. colonization is, however, potentially more serious than Aspergillus sp.
colonization in patients with cystic fibrosis, since the latter becomes
a contraindication to lung transplantation only if the patient has
additionally either an aspergilloma with pleural involvement or
allergic bronchopulmonary aspergillosis with a large steroid
requirement. In contrast, Scedosporium sp.-colonized lung
transplant candidates may be excluded per se because of the therapeutic
difficulties involved when invasive disease develops after transplantation.
S. apiospermum isolates of one IGS PCR type predominated
among RMU inpatients. This could suggest that transmission might have
occurred on the RMU. Two other explanations should also be considered.
First, isolates of the B type might have a tropism for patients with
chronic suppurative lung disease. Against this possibility are the
observations that (i) isolates with multiple types (six types) were
isolated from patients with cystic fibrosis and bronchiectasis, (ii)
type B isolates were recovered only from the subset of these patients
who were epidemiologically linked with the RMU, and (iii) type B
isolates were isolated from respiratory specimens of many RMU patients
with other diagnoses. The second possible explanation is that isolates
of type B are more common than those of other types. The observation
that a type B isolate was recovered from one patient with no apparent
connection with the RMU, but who lived in the same metropolitan area,
is the only circumstantial evidence in support of this hypothesis.
A means of S. apiospermum transmission was not determined.
An environmental reservoir was not discovered, since environmental sampling did not yield Scedosporium sp. isolates. There was
no evidence of person-to-person transmission, since, with the exception of the young adults with cystic fibrosis who attended the ward together
(and who also met outside the hospital), there was no evidence of
direct patient interaction. For the majority of RMU patients from whom
isolates with IGS PCR type B were recovered, the inpatient periods did
not overlap. Isolates with type C were recovered from two patients who
were frequent RMU inpatients and who were admitted on one occasion at
the same time. The significance of this is uncertain.
This is the first report of molecular typing of a collection of
clinical isolates of S. apiospermum. We have demonstrated that S. apiospermum isolates of the same IGS PCR type can be
recovered from some patients with chronic suppurative lung disease over a prolonged period of time and that multiple isolates of different IGS
PCR types can be recovered over relatively short periods of time from
the same patient. The predominance of a particular IGS PCR type
associated with the RMU could suggest that a common source infects
patients with chronic suppurative lung disease and other susceptible
patients, but the lack of other molecular characterization permits only
tentative conclusions. Molecular typing of this species by another
method is therefore required to help establish the epidemiology of this
species. Due to the significance of this isolate for potential lung
transplantation candidates, understanding the epidemiology of this
fungus should help in its future management.
 |
ACKNOWLEDGMENTS |
Tom Riley provided financial support for this project.
The staff of the Molecular Diagnostics Laboratory and Gracy Cherian of
the Mycology Laboratory, PathCentre, gave technical assistance.
Infection control nurses Helen Cadwallader and Anne Dyson assisted with
environmental sampling and tracing admission records. David Ellis of
the Mycology Laboratory, Women and Children's Hospital, Adelaide,
kindly provided fungal isolates from elsewhere in Australia.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Microbiology, St. John's Hospital, Howden Rd. West, Livingston EH54
6PP, Scotland. Phone: 44 1506 419666. Fax: 44 1506 460301. E-mail: Emma.Williamson{at}wlt.scot.nhs.uk.
 |
REFERENCES |
| 1.
|
Dworzack, D. L.,
R. B. Clark,
W. J. Borkowski,
D. L. Smith,
M. Dykstra,
M. P. Pugsley,
E. A. Horowitz,
T. L. Connolly,
D. L. McKinney,
M. K. Hostetler,
J. F. Fitzgibbons, and M. Galant.
1989.
Pseudallescheria boydii brain abscess: association with near drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses.
Medicine
68:218-224[Medline].
|
| 2.
|
Galgiani, J. N.,
D. A. Stevens,
J. R. Graybill,
D. L. Stevens,
A. J. Tillinghast, and H. B. Levine.
1984.
Pseudallescheria boydii infections treated with ketoconazole.
Chest
86:219-224[Abstract/Free Full Text].
|
| 3.
|
Garcia-Arata, M. I.,
M. J. Otero,
M. Zomeno,
M. A. de la Figuera,
M. C. de las Cuevas, and M. Lopez-Brea.
1996.
Scedosporium apiospermum pneumonia after autologous bone marrow transplantation.
Eur. J. Clin. Microbiol. Infect. Dis.
15:600-603[CrossRef][Medline].
|
| 4.
|
Grigg, A. P.,
P. Phillips,
S. Durham, and J. D. Shepherd.
1993.
Recurrent Pseudallescheria boydii sinusitis in acute leukemia.
Scand. J. Infect. Dis.
25:263-267[Medline].
|
| 5.
|
Gumbart, C. H.
1983.
Pseudallescheria boydii infection after bone marrow transplantation.
Ann. Intern. Med.
99:193-194.
|
| 6.
|
Issakainen, J.,
J. Jalava,
E. Eerola, and C. K. Campbell.
1997.
Relatedness of Pseudallescheria, Scedosporium and Graphium pro parte based on SSU rRNA sequences.
J. Med. Vet. Mycol.
35:389-398[Medline].
|
| 7.
|
Kathuria, S. K., and J. Rippon.
1982.
Nonaspergillus aspergilloma.
Am. J. Clin. Pathol.
78:870-873[Medline].
|
| 8.
|
Kostman, J. R.,
T. D. Edlind,
J. LiPuma, and T. L. Stull.
1992.
Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping.
J. Clin. Microbiol.
30:2084-2087[Abstract/Free Full Text].
|
| 9.
|
Lake, F. R.,
A. E. Tribe,
R. McAleer,
J. Froudist, and P. J. Thompson.
1990.
Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus.
Thorax
45:489-492[Abstract].
|
| 10.
|
Lopez, F. A.,
R. S. Crowley,
L. Wastila,
H. A. Valantine, and J. S. Remington.
1998.
Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity.
J. Heart Lung Transplant.
17:321-324[Medline].
|
| 11.
|
Maurer, J. R.,
A. E. Frost,
A. R. Glanville,
M. Estene, and T. Higenbottam.
1998.
International guidelines for the selection of lung transplant candidates.
Am. J. Respir. Crit. Care Med.
158:335-339[Free Full Text].
|
| 12.
|
Neuvéglise, C.,
J. Sarfati,
J. P. Debeaupuuis,
H. Vu Thien,
J. Just,
G. Tournier, and J.-P. Latgé.
1997.
Longitudinal study of Aspergillus fumigatus strains isolated from cystic fibrosis patients.
Eur. J. Clin. Microbiol. Infect. Dis.
16:747-750[CrossRef][Medline].
|
| 13.
|
Paradowski, L. J.
1997.
Saprophytic fungal infections and lung transplantation revisited.
J. Heart Lung Transplant.
16:524-531[Medline].
|
| 14.
|
Radford, S. A.,
E. M. Johnson,
J. P. Leeming,
M. R. Millar,
J. M. Cornish,
A. B. M. Foot, and D. W. Warnock.
1998.
Molecular epidemiological study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences.
J. Clin. Microbiol.
36:1294-1299[Abstract/Free Full Text].
|
| 15.
|
San Millán, R.,
G. Quindós,
J. Garaizar,
R. Salesa,
J. Guarro, and J. Pontón.
1997.
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.
J. Clin. Microbiol.
35:2270-2274[Abstract].
|
| 16.
|
Tekavec, J.,
E. Mlinaric-Missoni, and V. Babic-Vazic.
1997.
Pulmonary tuberculosis associated with invasive pseudallescheriasis.
Chest
111:508-511[Abstract/Free Full Text].
|
| 17.
|
Verweij, P. E.,
J. F. G. M. Meis,
J. Sarfati,
J. A. A. Hoogkamp-Korstanje,
J.-P. Latgé, and W. J. G. Melchers.
1996.
Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.
J. Clin. Microbiol.
34:2595-2597[Abstract].
|
Journal of Clinical Microbiology, January 2001, p. 47-50, Vol. 39, No. 1
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.47-50.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., Rinaldi, M. G., Shea, Y. R., Zaoutis, T., Kottilil, S., Walsh, T. J.
(2008). Infections Caused by Scedosporium spp.. Clin. Microbiol. Rev.
21: 157-197
[Abstract]
[Full Text]
-
Defontaine, A., Zouhair, R., Cimon, B., Carrere, J., Bailly, E., Symoens, F., Diouri, M., Hallet, J.-N., Bouchara, J.-P.
(2002). Genotyping Study of Scedosporium apiospermum Isolates from Patients with Cystic Fibrosis. J. Clin. Microbiol.
40: 2108-2114
[Abstract]
[Full Text]